Implementing TRBC1 immunohistochemistry in daily pathology practice

Valentina Nardi1, Mats Ehinger2, Daphne de Jong3

  • 1Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

Histopathology
|August 6, 2025
PubMed

Insights

The novel TCRBC1 antibody enhances immunohistochemistry for diagnosing blood cancers. Its implementation in diagnostic algorithms is recommended for improved accuracy in hematopathology.

Area of Science:

  • Hematopathology
  • Immunohistochemistry
  • Molecular Diagnostics

Background:

  • Differential diagnosis in hematopathology presents challenges.
  • Novel biomarkers are crucial for accurate hematological disease classification.

Discussion:

  • The TCRBC1 antibody offers significant added value in immunohistochemistry.
  • It aids in distinguishing between various hematological conditions.

Key Insights:

  • TCRBC1 antibody facilitates precise differential diagnostics in hematopathology.
  • Immunohistochemistry using TCRBC1 improves diagnostic accuracy.

Outlook:

  • Promoting the implementation of TCRBC1 antibody in routine diagnostic workflows.
  • Future integration of TCRBC1 into established hematopathology algorithms.